<unk> , sold under the brand name<unk> lid, is a medication used to reduce the risk of thrombotic strokes. It is an antiplatelet drug in the thienopyridine family which is an adenosine diphosphate (ADP) receptor inhibitor. Research initially showed that it was useful for preventing strokes and coronary stent occlusions. However, because of its rare but serious side effects of neutropenia and thrombotic thrombocytopenic purpura it was primarily used in patients in whom aspirin was not tolerated, or in whom dual antiplatelet therapy was desirable. With the advent of newer and safer antiplatelet drugs such as clopidogrel and<unk> agrelor, its use remained limited. It was patented in 1973 and approved for medical use in 1978.
Ticlopidine
Prokarin
Rivaroxaban
Palladin
Eptifibatide
Apixaban
Ticagrelor
Heparin